D. Vittecoq

发表

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

C. Katlama, J. Gatell, A. Lazzarin, 2007, The Lancet.

First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia

T. Naas, D. Vittecoq, N. Fortineau, 2016, Antimicrobial Agents and Chemotherapy.

[Propriospinal myoclonus in a HIV seropositive patient].

M. Vidailhet, F. Chain, D. Vittecoq, 1994, Revue neurologique.

Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010

P. Morlat, G. Geri, P. Cacoub, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): the cost of a failure in the systematic screening

F. Saliba, D. Vittecoq, S. Bouam, 2013, Antimicrobial Resistance and Infection Control.

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.

J. Gallant, S. Staszewski, J. Hulot, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs

F. Conti, M. Delahousse, G. Peytavin, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients

B. Dautzenberg, J. Pellegrin, C. Truffot-Pernot, 1996, Antimicrobial agents and chemotherapy.

Factors associated with survival in human immunodeficiency virus-positive patients and disseminated Mycobacterium avium complex infection.

D. Mathieu, D. Vittecoq, V. Vincent, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.

F. Dabis, M. Alvarez, J. Trinchet, 2012, Journal of hepatology.

The SPICE Study: 48‐Week Activity of Combinations of Saquinavir Soft Gelatin and Nelfinavir With and Without Nucleoside Analogues

M. Opravil, N. Clumeck, A. Pozniak, 2000, Journal of acquired immune deficiency syndromes.

The intestinal microbiota predisposes to traveller’s diarrhoea and to the carriage of multidrug-resistant Enterobacteriaceae after travelling to tropical regions

J. Schrenzel, V. Lazarevic, M. Esposito‐Farèse, 2018, bioRxiv.

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010

D. Neau, P. Morlat, F. Dabis, 2010, BMC infectious diseases.

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.

D. Neau, P. Morlat, F. Dabis, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Wildo Navegantes de Araújo, M. Ziol, V. Paradis, 2019, AIDS and Behavior.

Save antibiotics. What can be done to prevent a forecasted disaster! Suggestions to promote the development of new antibiotics.

R. Cohen, D. Vittecoq, R. Gauzit, 2010, Medecine et maladies infectieuses.

What can be done to prevent a forecasted disaster ! Suggestions to promote the development of new antibiotics Sauver les antibiotiques !

R. Cohen, D. Vittecoq, J. Stahl, 2010 .

Polymerase chain reaction (PCR) in various stages of HIV infection. Relationship to disease progression.

E. Wattel, P. Rouger, D. Vittecoq, 1991, Nouvelle revue francaise d'hematologie.

DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals.

P. Rouger, D. Vittecoq, J. Lefrère, 1990, AIDS.

No evidence of frequent human immunodeficiency virus type 1 infection in seronegative at‐risk individuals

P. Rouger, D. Vittecoq, J. Lefrère, 1991, Transfusion.

Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals

P. Rouger, D. Vittecoq, J. Lefrère, 1990, The Lancet.

ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS

B. Autran, J. Chermann, F. Rey, 1987, The Lancet.

Enfuvirtide: A safe and effective antiretroviral agent for human immunodeficiency virus–infected patients shortly after liver transplantation

D. Samuel, L. Bonhomme-Faivre, D. Vittecoq, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft

D. Samuel, G. Peytavin, L. Bonhomme-Faivre, 2013, AIDS.

Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis

A. Péchinot, G. Béraud, G. Barnaud, 2022, Infection.

Coronary heart disease in HIV-infected individuals.

G. Chironi, M. Merad, D. Vittecoq, 2003, Advances in cardiology.

Abacavir rechallenge has to be avoided in case of hypersensitivity reaction.

D. Vittecoq, E. Albengres, L. Escaut, 1999, AIDS.

Renal safety of tenofovir in HIV treatment-experienced patients

J. Hulot, H. Izzedine, A. Cheng, 2004, AIDS.

Coronary artery disease in HIV infected patients

A. Simon, G. Chironi, M. Merad, 2003, Intensive Care Medicine.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PLoS ONE.

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

C. Katlama, D. Neau, P. Morlat, 2018, PloS one.

Hospitalization of HIV positive patients: Significant demand affecting all hospital sectors.

L. Meyer, J. Lelièvre, C. Rapp, 2017, Revue d'epidemiologie et de sante publique.

HIV-associated vascular diseases: structural and functional changes, clinical implications.

C. Couzigou, B. Wyplosz, D. Vittecoq, 2009, International journal of cardiology.

Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

F. Vandenesch, A. Péchinot, G. Béraud, 2021, Infection.

Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients

D. Samuel, H. François, A. Durrbach, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Prognosis of ruptured intracranial mycotic aneurysms: a review of 12 cases.

D. Vittecoq, C. Goujon, J. Monsuez, 1989, European heart journal.

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

S. Fournier, D. Vittecoq, L. Escaut, 2017, Medecine et maladies infectieuses.

MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine

M. Mouroux, V. Calvez, C. Katlama, 2001, HIV medicine.

Infection a cytomegalovirus (CMV) et syndrome d'immunodepression acquise (SIDA)

D. Vittecoq, 1988 .

Lung in acquired immune deficiency syndrome: infectious and immunological status assessed by bronchoalveolar lavage.

C. Rouzioux, B. Régnier, F. Clavel, 1985, Bulletin europeen de physiopathologie respiratoire.

Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis.

D. Vittecoq, A. Meulemans, J. Decazes, 1986, The Journal of antimicrobial chemotherapy.

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia.

C. Couzigou, K. Lacombe, D. Vittecoq, 2007, Travel medicine and infectious disease.

Mitochondrial Damage Associated With Long‐Term Antiretroviral Treatment: Associated Alteration or Causal Disorder?

T. Maisonobe, C. Jardel, A. Lombès, 2002, Journal of acquired immune deficiency syndromes.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

M. Esposito‐Farèse, J. Lucet, B. Coignard, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

V. de Lédinghen, D. Neau, P. Morlat, 2019, PloS one.

Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

B. Iung, A. Péchinot, T. Doco‐Lecompte, 2022, Infectious Diseases and Therapy.

Impaired in-vitro proliferation of hemopoietic precursors in HIV-1-infected subjects.

V. Georgoulias, C. Jasmin, Y. Lunardi-Iskandar, 1989, Leukemia research.

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study

F. Vandenesch, A. Péchinot, G. Béraud, 2022, Advances in Therapy.

Initial human herpesvirus-8 rash and multicentric Castleman disease.

N. Dupin, B. Wyplosz, C. Guettier, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virological and Immunological Data of AIDS Patients Treated by Passive Immunotherapy (Transfusions of Plasma Rich in HIV‐1 Antibodies)

F. Roudot-thoraval, F. Barré-Sinoussi, D. Vittecoq, 1997, Vox sanguinis.

Antiretroviral Therapy and Sustained Virological Response to HCV Therapy are Associated with Slower Liver Fibrosis Progression in HIV–HCV-Coinfected Patients: Study from the Anrs Co 13 Hepavih Cohort

F. Dabis, A. Gervais, D. Vittecoq, 2012, Antiviral therapy.

Efficacy of etravirine for treatment of acute HIV meningoencephalitis.

C. Couzigou, D. Vittecoq, A. Roque-Afonso, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Poor tolerance of zidovudine in an HIV-asymptomatic patient with α-thalassemia

J. Bach, D. Vittecoq, E. Delabesse, 1991 .

Les pneumocystoses extra-pulmonaires*

D. Vittecoq, 1990 .

Vascular complications associated with use of HIV protease inhibitors

D. Vittecoq, L. Escaut, J. Monsuez, 1998, The Lancet.

Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease.

W. Rozenbaum, E. Kinney, I. Gorin, 1988, The American journal of cardiology.

[Corneal manifestations of measles in the unvaccinated adult: two typical cases during an epidemic].

S. Rebaudet, M. Labetoulle, M. M'garrech, 2013, Journal francais d'ophtalmologie.

Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis

A. Péchinot, G. Béraud, G. Barnaud, 2022, Infection.

Treatment of AIDS-Associated Heart Disease

E. Kinney, D. Vittecoq, J. Monsuez, 1989, Angiology.

The pavia consensus statement.

P. Volberding, M. Moroni, R. Bruno, 2003, AIDS.

Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone.

E. Denamur, O. Clermont, C. Branger, 2010, The Journal of antimicrobial chemotherapy.

Reduced Reactive Hyperemia in HIV‐Infected Patients

E. Vicaut, J. Dufaux, D. Vittecoq, 2000, Journal of acquired immune deficiency syndromes.

An unusual cause of hemorrhagic left pleural effusion.

P. Mackowiak, E. Fadel, D. Vittecoq, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neutropenia due to beta lactamine antibodies.

B. Régnier, K. Lassoued, D. Vittecoq, 1983, British medical journal.

PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

O. Decaux, S. Pol, L. Musset, 2015, Journal of hepatology.

Central venous catheters cvc in aids risk factors for bacterial infection

P. Berche, J. Bach, D. Vittecoq, 1990 .

Hemorheology in asymptomatic HIV-infected patients.

E. Vicaut, J. Dufaux, D. Vittecoq, 2000, Clinical hemorheology and microcirculation.

Acute HIV infection after acupuncture treatments.

C. Rouzioux, J. Bach, D. Vittecoq, 1989, The New England journal of medicine.

[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)].

D. Samuel, M. Mamzer-Bruneel, D. Malvy, 2009, Medecine et maladies infectieuses.

[Vaccinations of HIV-infected travelers].

C. Couzigou, D. Vittecoq, P. Bourée, 2009, Medecine et maladies infectieuses.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient.

D. Vittecoq, P. Sellier, J. Monsuez, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis

D. Vittecoq, A. Meulemans, M. Wolff, 1983, Antimicrobial Agents and Chemotherapy.

Toxoplasma parasitaemia associated with serological reactivation of chronic toxoplasmosis in a patient with the acquired immunodeficiency syndrome.

F. Derouin, D. Vittecoq, A. Bussel, 1987, The Journal of infection.

Pulmonary Localization of Enterocytozoon bieneusi in an AIDS Patient: Case Report and Review

D. Vittecoq, F. Botterel, P. Bourée, 2002, Journal of Clinical Microbiology.

Prolonged fever revealing disseminated infection due to Penicillium marneffei in a French HIV-seropositive patient.

D. Vittecoq, F. Botterel, P. Roger, 1999, AIDS.

Fanconi syndrome associated with cidofovir therapy

D. Vittecoq, G. Deray, L. Dumitrescu, 1997, Antimicrobial agents and chemotherapy.

Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial

C. Katlama, P. Bierling, P. Morlat, 2009, Journal of acquired immune deficiency syndromes.

Enhanced Saquinavir Exposure in Human Immunodeficiency Virus Type 1-Infected Patients with Diarrhea and/or Wasting Syndrome

Pascal Pernet, X. Panhard, J. Gobert, 2004, Antimicrobial Agents and Chemotherapy.

Intestinal absorption and permeability in human immunodeficiency virus-infected patients.

P. Pernet, D. Vittecoq, C. Aussel, 1999, Scandinavian journal of gastroenterology.

Enhanced risk of HIV sexual transmission during structured treatment interruption

D. Vittecoq, E. Teicher, T. Casagrande, 2003, Sexually transmitted infections.

Liver transplantation in patients with HIV infection.

D. Samuel, D. Vittecoq, J. Duclos Vallée, 2003, Journal of hepatology.

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

D. Samuel, H. Bismuth, C. Féray, 2007, Hepatology.

Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[Hepatic involvement in the acquired immunodeficiency syndrome. Study of 20 cases].

D. Vittecoq, C. Penalba, M. Cerf, 1985, Presse medicale.

Short Reviews on Liver Transplantation Liver transplantation in patients with HIV infection

D. Samuel, D. Vittecoq, E. Teicher, 2003 .

Urolithiasis in HIV-positive patients treated with atazanavir.

D. Neau, M. Daudon, C. Couzigou, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

D. Samuel, L. Bonhomme-Faivre, D. Vittecoq, 2007, Clinical pharmacokinetics.

Transient insulin-dependent diabetes mellitus in an HIV-infected patient receiving didanosine.

D. Vittecoq, I. Aupérin, D. Zucman, 1994, AIDS.

Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients

A. Barrier, B. Debuire, B. Falissard, 2004, Laboratory Investigation.

Amplification de l'ADN par la méthode de « Polymerase Chain Reaction(PCR) appliquée à la détection de séquences VIH-1 chez des sujets séropositifs et des sujets séronégatifs à risque

P. Rouger, D. Vittecoq, J. Lefrère, 1989 .

AIDS IN A BLACK MALIAN

D. Vittecoq, J. Modai, 1983, The Lancet.

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

A. LaMarca, B. Clotet, C. Katlama, 2012, The Journal of infectious diseases.

Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2.

V. Georgoulias, J. Chermann, M. Nugeyre, 1987, Leukemia research.

GASTROINTESTINAL INFECTIONS DURING AIDS

B. Régnier, D. Vittecoq, S. Matheron, 1984, The Lancet.

Possible correlation between exposure to aids risk factors, clinical presentation in aids, and subsequent prognosis

W. Rozenbaum, A. Messiah, D. Vittecoq, 1989, European Journal of Epidemiology.

Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature

N. Dupin, O. Chosidow, J. Molina, 2023, Acta dermato-venereologica.

Persistence of Yellow Fever Vaccine–Induced Antibodies After Solid Organ Transplantation

D. Samuel, M. Mamzer-Bruneel, H. François, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[Valganciclovir maintenance therapy in AIDS: treatment failure due to the development of cytomegalovirus resistance to ganciclovir].

C. Couzigou, M. Merad, D. Vittecoq, 2005, Medecine et maladies infectieuses.

Cytokines in HIV-associated cardiomyopathy.

D. Vittecoq, J. Monsuez, J. Charniot, 2007, International journal of cardiology.

Treatment of Pseudomonas aeruginosa meningitis with ceftazidime.

D. Vittecoq, A. Meulemans, J. Modai, 1983, The Journal of antimicrobial chemotherapy.

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial

C. Charpentier, C. Katlama, C. Fagard, 2012, Journal of acquired immune deficiency syndromes.

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.

D. Neau, P. Morlat, F. Dabis, 2017, Journal of hepatology.

Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era

A. Simon, G. Chironi, M. Andréjak, 2003, AIDS.

Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts

L. Meyer, P. Yeni, D. Vittecoq, 2013, PloS one.

Acquired immunodeficiency syndrome (AIDS) in Africans.

F. Brun-Vézinet, C. Katlama, C. Rouzioux, 1984, Annales de la Societe belge de medecine tropicale.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).

A. Samri, B. Autran, D. Samuel, 2009, Journal of hepatology.

Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?

I. Sobhani, D. Vittecoq, J. Salomon, 2017, The Journal of hospital infection.

[Adrenal lesions in AIDS: anatomopathological study].

D. Vittecoq, C. Perronne, S. Matheron, 1987, Annales de medecine interne.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation

D. Samuel, A. Coilly, D. Vittecoq, 2015, AIDS.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.

M. Esposito‐Farèse, J. Lucet, B. Coignard, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[DNA amplification using the polymerase chain reaction method applied to the detection of HIV-1 in seropositive subjects and in seronegative subjects at risk].

P. Rouger, D. Vittecoq, J. Lefrère, 1989, Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine.

Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo‐controlled trial in AIDS patients

W. Rozenbaum, D. Vittecoq, S. Gharakhanian, 2000, European journal of haematology.

Recovery from myasthenia gravis of a patient infected with human immunodeficiency virus.

B. Eymard, J. Bach, D. Vittecoq, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prognostic value of blood and bone marrow T-colony-forming cells (T-CFC) in patients with lymphadenopathy syndrome (LAS).

V. Georgoulias, W. Rozenbaum, C. Jasmin, 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Reduced reactive hyperemia in HIV-infected patients.

E. Vicaut, J. Dufaux, D. Vittecoq, 2000 .

Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis

D. Vittecoq, A. Meulemans, M. Wolff, 1986, Antimicrobial Agents and Chemotherapy.

Cerebrovascular diseases in HIV-infected patients.

C. Couzigou, B. Wyplosz, D. Vittecoq, 2009, Current HIV research.

Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.

B. Debuire, F. Chiappini, D. Vittecoq, 2009, Current HIV research.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

D. Neau, P. Morlat, C. Michelet, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).

V. Calvez, G. Carcelain, R. Tubiana, 2005, Vaccine.

LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT

B. Autran, J. Chermann, D. Vittecoq, 1986, The Lancet.

Risk of female-to-male transmission of HIV from women infected by transfusion.

D. Vittecoq, J. Lefrère, M. North, 1988, AIDS.

Carotid Intima-Media Thickness in Heavily Pretreated HIV-Infected Patients

A. Simon, J. Gariépy, G. Chironi, 2003 .

Differential improvement in survival among patients with AIDS after the introduction of HAART

J. Desenclos, Y. Le Strat, C. Couzigou, 2007, AIDS care.

The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in Europe.

M. Johnson, M. Opravil, N. Clumeck, 2000 .

Mitochondrial Damage in HIV Patients treated with Highly Active Antiretroviral Therapy

T. Maisonobe, C. Jardel, A. Lombès, 2002 .

Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy.

G. Carcelain, D. Vittecoq, P. Sellier, 2000, The American journal of medicine.

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.

D. Samuel, H. Bismuth, C. Féray, 2005, Journal of hepatology.

Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients.

A. Simon, J. Gariépy, G. Chironi, 2003, Journal of acquired immune deficiency syndromes.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

D. Benhamou, F. Brun-Vézinet, Y. Yazdanpanah, 2021, The Lancet.

Response of HIV-1-associated polymyositis to intravenous immunoglobulin.

J. Bach, D. Vittecoq, J. Viard, 1992, The American journal of medicine.

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

O. Decaux, S. Pol, L. Musset, 2013, Annals of the rheumatic diseases.

Generic drug prescriptions following hospital discharge: a prospective study in France.

B. Wyplosz, D. Vittecoq, P. Cavalié, 2011, European journal of internal medicine.

Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.

I. Sobhani, D. Vittecoq, P. Ronco, 2018, The Journal of hospital infection.

Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

C. Katlama, J. Gatell, A. Lazzarin, 2010, Journal of acquired immune deficiency syndromes.

Vapreotide, a somatostatin analogue, in cryptosporidiosis and other AIDS‐related diarrhoeal diseases

A. Schally, D. Vittecoq, E. Goldschmidt, 1992, AIDS.

Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma.

F. Barré-Sinoussi, C. Rouzioux, J. Bach, 1992, The Journal of infectious diseases.

Liver transplantation in HIV-infected patients

D. Samuel, D. Vittecoq, J. Duclos‐Vallée, 2006 .

Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.

S. Chevret, F. Barré-Sinoussi, D. Vittecoq, 1995, Proceedings of the National Academy of Sciences of the United States of America.

[Castleman's disease in patients infected with HIV].

D. Vittecoq, O. Blétry, B. Dupont, 2002, La Revue de medecine interne.

Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.

C. Katlama, D. Neau, P. Morlat, 2019, European journal of gastroenterology & hepatology.

LA CRYPTOCOCCOSE : MISE AU POINT

D. Vittecoq, P. Tattevin, 1998 .

Save antibiotics! What can be done to prevent a forecasted disaster? Suggestions to promote the development of new antibiotics☆☆☆

F. Trémolières, R. Cohen, Rémy Gauzit, 2010 .

Infectious complications after liver transplantation in human immunodeficiency virus‐infected recipients

D. Samuel, O. Lambotte, A. Coilly, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

P0837 : Efficacy of sofosbuvir and daclatasvir in HIV/HCV co-infected patients with advanced fibrosis

D. Samuel, A. Coilly, D. Vittecoq, 2015 .

Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus.

B. Autran, L. Musset, D. Vittecoq, 1998, Arthritis and rheumatism.

[Stomatological lesions seen in HIV infection. 1. Clinical study. Apropos 111 cases].

D. Vittecoq, J. Laufer, C. Brocheriou, 1987, Revue de stomatologie et de chirurgie maxillo-faciale.

Pneumocystis carinii pneumonia in patients with breast cancer: are there contributing local factors?

D. Vittecoq, P. Tattevin, M. di Palma, 1998, Clinical Infectious Diseases.

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

C. Rouzioux, W. Rozenbaum, D. Guétard, 1989, AIDS.

Circulating anticoagulant in the acquired immunodeficiency syndrome.

D. Vittecoq, J. Lefrère, D. Gozin, 1987, Annals of internal medicine.

13 Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre

D. Samuel, H. Bismuth, C. Féray, 2006 .

HCV VIRAL RECURRENCE AND LIVER MITOCHONDRIAL DAMAGE AFTER LIVER TRANSPLANTATION (LT) IN HIV-HCV COINFECTED PATIENTS

D. Samuel, H. Bismuth, C. Jardel, 2004 .

124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients

D. Samuel, C. Féray, F. Saliba, 2004 .

[Streptococcal meningitis following radiculography with metrizamide].

D. Vittecoq, J. Modai, 1984, Presse medicale.

High-performance liquid chromatographic analysis of azthreonam in tissues and body fluids.

J. Mohler, D. Vittecoq, A. Meulemans, 1986, Journal of chromatography.

Enhanced risk of HIV sexual transmission during structured treatment interruption

R. Miller, D. Vittecoq, D. Daniels, 2022 .

La transplantation hépatique chez les patients co-infectés VIH/VHC et VIH/VHB

D. Samuel, D. Vittecoq, E. Teicher, 2007 .

Sinusites aspergillaires invasives chez les patients infectés par le virus de l'immunodéficience humaine

D. Vittecoq, P. Géhanno, O. Bouchaud, 1999 .

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, BMC Infectious Diseases.

Legionella pneumophila: persistent positive sputum culture in an HIV-infected patient.

D. Vittecoq, P. Tattevin, J. Monsuez, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Liver transplantation in patients with HIV infection.

D. Samuel, D. Vittecoq, J. Duclos Vallée, 2003, Journal of hepatology.

La transplantation hépatique est-elle possible chez les patients co-infectés par le VIH et le VHC ?

M. Merad, D. Vittecoq, E. Dussaix, 2003 .

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial

C. Charpentier, C. Katlama, C. Fagard, 2012, Journal of acquired immune deficiency syndromes.

Pulmonary hypertension associated with thrombotic thrombocytopaenic purpura in AIDS patients.

D. Vittecoq, I. Aupérin, J. Monsuez, 1997, European Heart Journal.

Is lymphocyte transfer a promising therapeutic approach towards AIDS?

D. Dormont, B. Autran, W. Rozenbaum, 1987, Annales de l'Institut Pasteur. Immunology.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Expanding the spectrum of HIV-associated myopathy

C. Duyckaerts, T. Maisonobe, O. Dubourg, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.